/ TerminatedNot Applicable A multicenter, open label, randomized, balanced, two treatment, two period, two sequence, two way crossover, single dose, bioequivalence study of Doxorubicin Hydrochloride Liposome Injection (2mg/mL) (10mL) of Onco Therapies Limited, Bangalore, India with Doxil®Doxorubicin HCl liposome injection, 20mg in 10mL (2 mg/mL) Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146 Manufactured for: Janssen Products, LP Horsham, PA 19044 administered in female patients with ovarian cancer whose disease has progressed or recurred after platinum based chemotherapy under fed condition.
100 Clinical Results associated with Onco Therapies Ltd.
0 Patents (Medical) associated with Onco Therapies Ltd.
100 Deals associated with Onco Therapies Ltd.
100 Translational Medicine associated with Onco Therapies Ltd.